New obesity drugs may shift blame toward food industry

New obesity drugs may shift blame toward food industry

An essay presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) suggests that new age of obesity drugs could shift the blame for living with obesity from individuals to the food industry – just as smoking has been blamed on tobacco industry and to a lesser extent alcohol consumption on the alcohol industry.

Could the 'Ozempic Era' shift blame for obesity from individuals to the food industry?

An essay presented at the European Congress on Obesity in Istanbul, Turkey (12–15 May) suggests that a new age of obesity drugs could shift the blame for living with obesity from individuals to the food industry—just as smoking has been blamed on the tobacco industry and, to a lesser extent, alcohol consumption on the alcohol industry.